Rationale and design of a randomized trial on the effectiveness of aerobic interval training in patients with coronary artery disease : the SAINTEX-CAD study
van Craenenbroeck, Emeline M.
Faculty of Medicine and Health Sciences
University Hospital Antwerp
International journal of cardiology. - Amsterdam, 1981, currens
, p. 3532-3536
University of Antwerp
Background: Exercise-based cardiac rehabilitation is considered an important adjunct treatment and secondary prevention measure in patients with coronary artery disease (CAD). However, the issues of training modality and exercise intensity for CAD patients remain controversial. Objective: Main aim of the present study is to test the hypothesis that aerobic interval training (AIT) yields a larger gain in peak aerobic capacity (peakVO(2)) compared to a similar training programme of moderate continuous training (MCT) in CAD patients. Study design: In this multicentre study stable CAD patients with left ventricular ejection fraction > 40% will be randomized after recent myocardial infarction or revascularization (PCI or CABG) to a supervised 12-week programme of three weekly sessions of either AIT (85-90% of peak oxygen uptake [peakVO(2)], 90-95% of peak heart rate) or MCT (60-70% of peakVO2, 65-75% of peak heart rate). The primary endpoint of the study is the change of peakVO(2) after 12 weeks training. Secondary endpoints include safety, changes in peripheral endothelial vascular function, the evolution of traditional cardiovascular risk factors, quality of life and the number and function of circulating endothelial progenitor cells as well as endothelial microparticles. Possible differences in terms of long-term adherence to prescribed exercise regimens will be assessed by regular physical activity questionnaires, accelerometry and reassessment of peakVO(2) 12 months after randomization. A total number of 200 patients will be randomized in a 1: 1 manner (significance level of 0.05 and statistical power of 0.90). Enrolment started December 2010; last enrolment is expected for February 2013. (C) 2013 Published by Elsevier Ireland Ltd.